VivoLab AB

Merry Christmas y'all and please have wonderful Holidays 🎅 We would like to thank all of our partners for a wonderful 2023. More needs to be done to combat illness and to provide solid health solutions for children in need. VivoLab AB Bill & Melinda Gates Foundation UNICEF World Health Organization

Supernews! Our product family Breease® and miniBreease® is teaming up with URSATEC GmbH and will be sold via select customers. A big step forward for VivoLab AB

Supernews! Our product family Breease® and miniBreease® is teaming up with URSATEC GmbH and will be sold via select customers. A big step forward for VivoLab AB

Thank you CPHI for having us at CPHI Barcelona 2023 Loads of input and great opportunities! And thank you all current partners and future partners in coming endeavors 🚀 AstraZeneca BioVentureHub URSATEC GmbH Harro Höfliger Gerresheimer Aquilon Pharma Polpharma Dreavia SoftGroup Bormioli Pharma Aptar SHL Healthcare AB and SHL Medical See you all further down the road 🤘

VivoLab AB is excited to attend the Nordic Life Science Days in Copenhagen, Denmark on November 29-30! We invite our current and future partners, investors, and anyone else who wants to learn more about the world's coolest medtech development company to reach out and connect with us at the event. We'll be sharing some our latest innovations and looking for new opportunities to collaborate. We hope to see you there!

The terrorist act that killed two Swedish citizens is a heinous and cowardly act that must be condemned in the strongest possible terms. There is no justification for such violence, and it is an attack on the values of peace and tolerance that we hold dear. The victims of this attack were innocent people who were simply going to a soccer game. Their deaths are a tragic loss to their families and friends, and to the Swedish nation as a whole. We must stand together in the face of this act of terror, and show that we will not be intimidated by those who seek to divide us. To the families and friends of the victims, we offer our deepest condolences.

Exclusive Premier! 🎉 VivoLab AB have now together with AstraZeneca BioVentureHub showcased FRANK®, our new and 3D airway model for aerosol drug delivery Thank you all for visiting and supporting VivoLab AB at GOTogether Day #GOTogether #breakthrough #licenseopportunity

Exclusive Premier! 🎉 VivoLab AB have now together with AstraZeneca BioVentureHub showcased FRANK®, our new and 3D airway model for aerosol drug delivery Thank you all for visiting and supporting VivoLab AB at GOTogether Day #GOTogether #breakthrough #licenseopportunity

Our entry to AstraZeneca BioVentureHub has been a huge step forward. This week we will present our new and unique lung-deposition tool FRANKenstein on AstraZeneca main R&D site Mölndal. Please contact us for demo. For a growing company to have reach and connect with new and old partners it is crucial to communicate properly, so please follow us on LinkedIn. Thanks, VivoLab AB

Extremely proud to be a part of AstraZeneca BioVentureHub VivoLab AB will join a group of successful companies in BioVentureHub, both present and alumni. We have great things in the pipeline so stay tuned, add and follow VivoLab AB and AstraZeneca BioVentureHub for coming supercool solutions in respiratory health. Lars Thelin Mats Persson Martin Norling Robert Börjes Ulrika Edvardsson Pernilla Isberg Magnus R. Björsne, PhD, MBA, Assoc. Prof. Yorick Kamlag AWESOME!!! 😎 🚀